Health Care · Medicinal Chemicals & Botanical Products · Nasdaq · CIK 1562733 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.17Day +0.18%Mkt cap $3M1Y −95.3%Off 52W high −95.7%Vol (1Y) 82.8%
Daily closing price, split-adjusted to the current basis; 2.7y shown of 2,036 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.14% |
| Top-10 13F concentration99.9% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$27.7M |
| Earnings (TTM)-$15.8M |
| Net margin−40.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−90.8% |
| 1Y−95.3% |
| 3Y+1608.0% |
| 5Y+241.6% |
| 10Y−57.3% |
| Since incept. (ann.)−5.3% |
Price return through 2026-07-29 · series begins 2014-03-17. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)82.8% |
| Ann. volatility (3Y)1858.2% |
| Sharpe (1Y)−3.32 |
| Sharpe (3Y)0.81 |
| Max drawdown (1Y)−95.7% |
| Max drawdown (3Y)−97.1% |
| Beta (3Y vs SPY)10.62 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| HEARTLAND ADVISORS INC | 550,000 | $709,500 | 4.87% | +0.0% |
| GRATIA CAPITAL, LLC | 550,000 | $709,500 | 4.87% | −0.9% |
| SANDERS MORRIS HARRIS LLC | 415,452 | $535,933 | 3.68% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 89,770 | $115,803 | 0.79% | new |
| VANGUARD FIDUCIARY TRUST CO | 23,149 | $29,862 | 0.20% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 21,398 | $27,603 | 0.19% | −40.6% |
| Warberg Asset Management LLC | 10,222 | $13,186 | 0.09% | −25.3% |
| SOA Wealth Advisors, LLC. | 10,000 | $12,900 | 0.09% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.23 | −330.0% | $5.5M | −81.7% |
| 2025-12-31 | 2026-04-01 | — | — | $6.1M | −40.9% |
| 2025-09-30 | 2025-11-13 | $0.01 | — | $8.0M | +12.4% |
| 2025-06-30 | 2025-08-14 | $0.17 | — | $8.1M | +1.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Nutraceuticals 98% · Beverages 2% · Consumer Goods 0%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
